---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-000110"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:12:01.897944+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# KALA BIO enters $15M at-market offering agreement with H.C. Wainwright

## Summary
- Aggregate market value of shares eligible for sale under ATM prospectus supplement currently $15,000,000.
- Sales commission to H.C. Wainwright set at 3.0% of gross sales price.
- Company has no obligation to sell any shares under the agreement; either party may suspend offerings.
- Subject to terms, Wainwright may sell shares on Nasdaq or in privately negotiated transactions.

## SEC filing metadata
- accession: 0001829126-26-000110
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/0001829126-26-000110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/kalabio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-000110
- JSON: https://secwatch.observer/filing/0001829126-26-000110.json
- Plain text: https://secwatch.observer/filing/0001829126-26-000110.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.